A novel class of therapeutic protein based molecules

Details for Australian Patent Application No. 2005285461 (hide)

Owner Nexbio Inc

Inventors Malakhov, Michael; Fang, Fang

Agent Pegasus IP

Pub. Number AU-B-2005285461

PCT Pub. Number WO2006/031291

Priority 10/939,262 10.09.04 US

Filing date 21 July 2005

Wipo publication date 23 March 2006

Acceptance publication date 3 March 2011

International Classifications

C12N 9/00 (2006.01) Enzymes, e.g. ligases (6.)

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 1/20 (2006.01) Micro-organisms, e.g. protozoa - Bacteria

C12N 9/24 (2006.01) Enzymes, e.g. ligases (6.) - acting on glycosyl compounds (3.2)

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/031291 Priority application(s): WO2006/031291

17 February 2011 Assignment before Grant

  Malakhov, Michael; Fang, Fang The application has been assigned to Nexbio Inc

3 March 2011 Application Accepted

  Published as AU-B-2005285461

30 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005285463-Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia

2005285460-Free chlorine sensor